News: ANZUP

ENZAMET shows promise as prostate cancer treatment

The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology .

[Read more about ENZAMET shows promise as prostate cancer treatment ]